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Abstract
Objective: The study aims to investigate whether laparoscopic cholecystectomy (LC) is a cost-
effective strategy for managing gallbladder-stone disease compared to the conventional open
cholecystectomy(OC) in a Thai setting.
Design and Setting: Using a societal perspective a cost-utility analysis was employed to measure
programme cost and effectiveness of each management strategy. The costs borne by the hospital
and patients were collected from Chiang Rai regional hospital while the clinical outcomes were
summarised from a published systematic review of international and national literature. Incremental
cost per Quality Adjusted Life Year (QALY) derived from a decision tree model.
Results: The results reveal that at base-case scenario the incremental cost per QALY of moving
from OC to LC is 134,000 Baht under government perspective and 89,000 Baht under a societal
perspective. However, the probabilities that LC outweighed OC are not greater than 95% until the
ceiling ratio reaches 190,000 and 270,000 Baht per QALY using societal and government
perspective respectively.
Conclusion: The economic evaluation results of management options for gallstone disease in
Thailand differ from comparable previous studies conducted in developed countries which
indicated that LC was a cost-saving strategy. Differences were due mainly to hospital costs of post
operative inpatient care and value of lost working time. The LC option would be considered a cost-
effective option for Thailand at a threshold of three times per capita gross domestic product
recommended by the committee on the Millennium Development Goals.
Introduction
It is widely accepted that laparoscopic cholecystectomy
(LC) is the first-line treatment for uncomplicated gall-
stone disease in developed countries where up to 80% of
all cholecystectomy is performed through laparoscopy [1-
3].
In contrast to the conventional open cholecystectomy
(OC), which is performed through an approximately 15-
centimeter right sub-costal incision and commonly causes
a serious degree of postoperative pain and longer hospital
stay, LC is associated with a shorter hospitalization, more
rapid return to work and better quality of life, at least in
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the short and intermediate term (3 years) after the opera-
tion[4].
The saving of hospital costs by LC is, however, not yet in
agreement [5-8]] due to a higher operation cost which
contributes around 60% of total hospital costs[9]. Fur-
thermore, high complication rates were reported[10,11].
A meta-analysis also concludes that LC appeared to have
a higher rate of common bile duct injuries[12].
In Thailand, since LC was first introduced in 1993, its
adoption by healthcare providers has been relatively slow.
By 2001, LC accounted for only 17% of the overall rate of
cholecystectomy[13]. Some factors could explain the slow
diffusion rate of the new procedure in Thailand. Firstly,
the absence of financial incentives is believed to be a
major cause. Under the capitation of the largest public
insurance scheme, Universal Coverage Scheme (UC), OC
has been reimbursed, but not LC. Thus, up to 10,000 Baht
of co-payment by patients is needed if patients want lapar-
oscopic surgery. Unsurprisingly, the proportion of UC
patients undergoing LC, 13%, was the lowest across pub-
lic health insurance schemes[13].
Patients under Civil Servant Medical Benefit Scheme
(CSMBS) did not face the same financial disincentives.
The CSMBS, covering government employees and their
relatives, reimburses hospitals at a fixed rate for certain
surgical procedures but, unfortunately, reimbursement
rates set for OC and LC are alike, even though LC is asso-
ciated with a shorter hospital stay. CSMBS reimburses the
operation and hotel cost of hospital admission separately.
A better socioeconomic status among CSMBS beneficiar-
ies compared to UC may explain the greater LC
Decision tree illustrating the probable course of events for the management strategies being compared Figure 1
Decision tree illustrating the probable course of events for the management strategies being compared. A node in the repre-
sented by the box is the point of making decision between alternatives; nodes in the represented by the circle are points of 
events occurred.
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uptake[14]. LC accounted for 28% of all cholecystectomy
for these patients[13].
Secondly, the initial costs of setting up the equipment to
perform LC and need for training for surgical team might
have limited the ability of some hospitals to perform the
procedure and these hospitals are likely to continue the
status quo unless having strong support from Ministry of
Public Health[13].
Given the lack of uptake and the greater potential cost-
effectiveness, there is an urgent need to determine the
value for money of LC compared to the traditional OC.
Appropriate assessment of evidence may help to identify
whether LC should be reimbursed under the Thai public
insurance system. The aim of the present study is to inves-
tigate whether LC is a cost-effective strategy for managing
gallbladder stone disease in the setting of Thailand.
Although there are a number of economic evaluations on
LC versus OC[6,7,15-18]], no single study was conducted
in developing countries where cost burden may largely
differ from those in western countries. The study is also
conducted using societal perspective, which is recom-
mended for public reimbursement[19], but rarely found
in previous evaluations.
Materials and methods
Model
A decision tree validated by a group of experts in Thailand
was used to model all of the clinically important out-
comes of two different strategies for treating of gallbladder
stones--pro LC versus pro OC policy (Figure 1). The start
of the decision tree is the case of a patient who is eligible
for surgery for gallbladder stones--cholelithiasis, but the
management strategy of cholelithiasis will differ based on
whether or not common bile duct (CBD) stones are pre-
sented. Surgeons do not know with certainty, which of
their patients with cholelithiasis actually have CBD
stones. This is accounted for by explicitly modelling the
effects of each strategy for the two different situations--
one where physician suspects the existing of CBD stones
e.g. acute pancreatitis, duct dilatation of CBD, obstructive
jaundice[2,20,21] and one where there are no suspected
signs and symptoms of having CBD stones.
The diagnosis of CBD stones or choledocholithiasis,
could be done by ultrasonography, intravenous cholangi-
ography, endoscopic retrograde cholangiography (ERCP)
or Magnetic Resonance Image (MRI). Cholangiography
and ERCP are most commonly used for definitive diagno-
sis in Thailand. Routine use of preoperative ERCP or intra-
operative cholangiography (IOC) yields very little benefit
for detection of CBD stones over and above that which is
obtained with selective policies[16]. Hence, all patients
without suspected CBD stones are directly assigned for LC
or OC. Only those undergoing LC the result may be suc-
cessful or unsuccessful (conversion from LC to OC). The
final outcome is either cure or having bile-duct injuries.
For the patients with suspected CBD stones under pro LC
policy, they will be assigned for ERCP or IOC depending
on availability of the procedure. For those with positive
IOC, open choledocholelithectomy is a choice of treat-
ment. On the other hand, patients with positive ERCP
undergo endoscopic sphincterotomy, and if it is unsuc-
cessful, then open choledocholelithectomy is performed.
Table 1: Corresponding transitional probabilities of epidemiological variables and the utility values
Input Variables Point estimates 
(mean)
Standard error for 
uncertainty analysis
Data sources
Epidemiological variables
Probability of having suspected signs of CBD stones 0.3439 0.0123 22–24
Probability of having CBD stones among suspected cases 0.2929 0.0455 1
Proportion of ERCP available for patients who need it 0.5000 0.0498 Expert opinion
Probability of conversion from LC to OC 0.0550 0.0010 12, 24, 26
Probability of bile duct injury among patients undergoing LC 0.0050 0.0003 12
Probability of bile duct injury among patients conversed from LC to OC 0.0030 0.0017 Expert opinion
Probability of bile duct injury among patients undergoing OC 0.0024 0.0004 12
Probability of bile duct injury among patients undergoing open explored CBD 0.0010 0.0010 Expert opinion
Probability of retained CBD stones after undergoing ERCP 0.1279 0.0358 24–26
Utility variables
Utility of case with completed OC 0.80 0.02 16
Utility of case with completed LC 0.90 0.02 16
Utility of case with bile-duct injury in the first year 0.80 0.02 16
Utility of case with bile-duct injury in the subsequent twenty years 0.89 0.01 16
CBD = common bile duct
ERCP = endoscopic retrograde cholangiopancreatograpy
LC = laparoscopic cholecystectomy
OC = open cholecystectomyCost Effectiveness and Resource Allocation 2005, 3:10 http://www.resource-allocation.com/content/3/1/10
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Under the pro OC policy the patients with suspected CBD
stones receive IOC and if positive, open choledocho-
lithectomy is the definitive treatment.
Estimation of parameter probabilities
All parameters for the model were obtained from a sys-
tematic review of national and international literature,
searching of Thai- and English-language studies. We iden-
tified all English language articles published up to year
2004 from Medline and EMBASE using searching key-
word "cholecystectomy". The Thai literature, including
related Masters and Docteral's dissertations, were also
identified using electronic and manual approach from
database at Library of Mahidol University. We initially
reviewed all identified abstracts. The full articles were con-
sidered if their objectives are about to quantify mortality,
morbidity, compliance and treatment costs.
The mortality outcome of the laparoscopic and open strat-
egies was considered to be equivalent[12]. A higher rate of
common bile duct injuries, but better quality of life in
short and intermediate terms were demonstrated for
LC[4,16]. A cost-utility analysis in terms of Baht per Qual-
ity Adjusted Life Year (QALY) was, therefore, selected as
the analytical approach.
Table 1 presents the probabilities for all clinical outcomes
in the model and the utility values, as well as the range
tested in sensitivity analysis. For example, the probability
of finding patients with suspected signs and symptoms of
having common bile duct stones was set at 0.3440 and its
standard error (SE) was 0.0123[22,23]. With the overall
incidence of CBD stones with among patients with chole-
lithiasis at 10%, the probability of having common bile-
duct stones among suspected cases was set at 0.293 with
SE of 0.045.
Updating the meta-analysis conducted by Shea et al[12]
the conversion rate from LC to OC was 0.055 (SE = 0.001)
and the probability of bile duct injury among patients
undergoing LC and OC were 0.0050 (SE = 0.0003) and
0.0024 (SE = 0.0024) respectively. A consensus from the
Thai expert panel meeting to review the model indicated
that a probability of bile duct injury among patients con-
versed from LC to OC should be something in between
the probabilities of injury among patients undergoing OC
and the probabilities of injury among patients undergoing
LC. We assumed the probability of 0.0030 and SE of
0.0017. The panel also indicated that a probability of bile
duct injury among patients undergoing open explored
CBD should be the lowest. We set the rate and its standard
error of 0.001. The meta-analysis of studies by Sangsub-
han et al[24], Rhodes et al[25], and Konstadoulakis et
al[26] found a probability of retained CBD stones after
undergoing ERCP at 0.128 (SE = 0.0358).
Utility
Laparoscopic cholecystectomy was superior to open
cholecystectomy in enhancing the quality of life for all eli-
gible patients. The most comprehensive quality of life
assessment study found from our review is of Cook et
al[16]. They conducted a prospective assessment from 96
members of the general public in Melbourne using a
standard questionnaire of which its questions included
frequency and intensity of clinical factors e.g. pain, nau-
sea, vomiting, identified from previous patient's inter-
views. We used their utility values and confidential
intervals adjusted by 12-month values as our utility inputs
Table 2: Costs (per patient) related to open and laparoscopic cholecystectomy, in 2004 Thai Baht, and used as inputs in the model
Open cholecystectomy Laparoscopic 
cholecystectomy
Variables Mean Standard error Mean Standard error
Direct costs
Cholecystectomy (pre-, intra-, and post-operation) 9,355 717 20,790 507
Conversion from Laparoscopic to open cholecystectomy 25,782 1,518
Intraoperative cholangiography (IOC) 1,502 154 1,502 154
Endoscopic retrograde cholangiopancreatography (ERCP) 2,011 120
Open choledocholithectomy 15,201 1,590 15,201 1,590
Endoscopic sphincterotomy 9,923 639
Treatment bile duct injury 12,068 2,926 12,068 2,926
Self-prescriptions and visiting private clinics (after discharge from hospital) 566 204 567 249
Indirect costs
Foods, accommodations, and lost working and spare times, on the part of relatives during 
admission
7,519 383 3,810 759
Lost working and spare times, on the part of relatives after discharging from hospital 2,945 1,409 2,693 650
Lost working and spare times, on the part of patients (on a whole course) 4,008 1,004 2,069 488
Transfer costs (i.e. sick compensations) 69 55 17 12Cost Effectiveness and Resource Allocation 2005, 3:10 http://www.resource-allocation.com/content/3/1/10
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(In fact, Topcu et al[4] indicated the difference in utility
between LC and OC at 36 months. We took conservative
estimation, assuming the difference of utility lasted by 12
months.)
Resource use parameters
In this study both direct and indirect costs borne by health
care providers and households were collected in two ways:
patient questionnaire interviews and data extraction from
hospital case notes.
Chiang Rai regional hospital was purposively selected for
costing study. This was the only public hospital that pro-
vided free of charge of LC and OC for UC beneficiaries,
while other public hospitals offered only OC free. The
prospective reviews of medical records of all patients
undergoing open or laparoscopic cholecystectomy during
September to November 2004 were performed. We also
conducted a retrospective medical record review for rare
conditions i.e. open choledocholithectomy, cases of con-
version from LC to OC, treatments for CBD injuries, and
endoscopic sphincterotomy, which had occurred in the
past two years (October 2002-September 2004).
The case note review aimed to measure hospital resources
consumed (e.g. clinician's time; type and number of
investigations, drugs, and disposable equipments; length
of hospital admission) in excess of usual preoperative,
operative, and postoperative care. To ensure comparabil-
ity of the groups, exclusion criteria were defined in such a
way that an OC could be compared with a LC. Of a total
of 80 medical records reviewed, 48 records (60%) of acute
cholecystitis patients initially presented with peritonitis,
sepsis, neoplasm, or co-existing conditions i.e. uncon-
trolled diabetes mellitus, uncontrolled hypertension were
excluded from the analysis.
The valuation of the hospital costs, including capital and
overhead costs, for each individual patient was deter-
mined from each department involved in the routine serv-
ices for patients with gallstones disease.
We completed micro-cost analysis of 15 cases of OC, 17
cases of LC, 7 cases of open choledocholithectomy, 3 case
of conversion from LC to OC, 3 case of treatment of CBD
injuries, and 1 case of endoscopic sphincterotomy. The
mean age was 60.8 years for patients underwent OC and
58.1 years for LC, there was no significant difference
(using the student t-test, p > =0.05).
Thirty-two patients who had the operation in October and
November 2004 were also contacted to determine indirect
costs. Daily event and cost questionnaires were used to
collect patient-specific information for estimation of
other household expenses e.g. travel costs, food, accom-
modation and opportunity loss from providing informal
care and visits of relatives and friends at hospital and
home, patient's recovery time to full activity after surgery.
We conducted face-to-face interviews with patients at the
post-operation visit (2–4 weeks after operation). For the
patients who did not get back to the hospital at all or hav-
ing longer follow-up period than 4 weeks, we used tele-
phone interview to collect that data.
Because of very low complication rates and no available
information on indirect costs related to complications, we
assumed in the model a similar indirect cost for patients
with and without complications.
The costs were represented in the model in Thai Baht in
2004 (40 Baht = 1USD or 75 Baht = 1 GBP). All costs and
outcomes occurred beyond one year were discounted
using the same rate of 3.5%.
Uncertainty analysis
To determine if values within a plausible range for all
input variables resulted in a different conclusion, we
undertook probabilistic uncertainty analysis, assigning a
beta distribution for all probability and utility parameters
and gamma distribution for all cost parameters, and gen-
erating 1,000 rounds of simulations using Microsoft
Excel® with macro function on all estimated quantities.
The cost-effectiveness acceptability curve based on the net
benefit approach is also provided to present the relation
between the values of the ceiling ratio (willingness to pay
for a unit more of QALY) and probability of favouring
each treatment strategy.
Table 3: Deterministic results from the model
Open cholecystectomy Laparoscopic cholecystectomy Incremental values
Programme cost using government perspective 11,000 23,000 12,000
Programme cost using societal perspective 26,000 33,000 7,000
Programme effectiveness (QALYs) 0.798 0.885 0.087
Cost per QALY using government perspective 134,000
Cost per QALY using societal perspective 89,000
Note: the costs and incremental values were given to nearest 1,000 Baht price levelCost Effectiveness and Resource Allocation 2005, 3:10 http://www.resource-allocation.com/content/3/1/10
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Results
Costs
Table 2 summarises all important cost parameters for use
in the economic evaluation model. It is worth noting that
the average hospital cost for OC in all 15 patients (9,355
Baht per OC case, SE = 717) was lower than the average
cost for LC in all 17 cases (20,790 Baht per LC case, SE =
507). However, length of hospital stay and time to full
recovery were markedly reduced in patients undergoing
LC (mean 3.8 days, SE 0.4) compared to those having OC
for LC (mean 6.1 days, SE 0.5) and, therefore, made a
much lower indirect cost (mean 8,617 Baht for LC versus
14,484 Baht for OC).
Cost-utility
Programme costs and outcome at base-case scenario for
each treatment strategy are demonstrated in table 3. The
programme costs are lower for pro OC policy in both
using government's and societal viewpoints. However, the
gap of programme costs (incremental cost) between the
two strategies is 42% [(12,000-7,000)/12,000] smaller in
the use of a societal viewpoint.
Pro OC and LC strategy provide 0.798 and 0.885 QALYs,
respectively. On the other hand, moving from a cheaper
and lower effectiveness strategy, pro OC, to pro LC policy
yields extra 0.087 QALYs.
When only direct costs were compared, an incremental
cost per QALY of moving from OC to LC is 134,000 Baht.
The incremental cost-effectiveness ratio decreases to
89,000 Baht per QALY when including indirect cost of a
wider societal perspective. Moving from OC to LC would
add a financial burden of 12,000 Baht per case to the gov-
ernment but offset the indirect costs of 5,000 Baht that is
presently shouldered by the households.
Uncertainty analysis
The cost-effectiveness acceptability curves in figure 2 sum-
marise the robustness of the model regarding uncertainty
estimation of the programme cost and effect for each
treatment strategy. At the zero ceiling ratio, indicating that
no further resources would be allocated to healthcare, pro
OC policy is a dominant strategy, particularly using a gov-
ernment perspective. When the ceiling ratios are greater
than 90,000 and 140,000 using government and societal
perspective respectively, pro LC policy becomes a prefera-
ble choice, offering a better chance of saving one QALY at
given money. However, the probabilities that LC out-
weighed OC are not greater than 95% until the ceiling
ratio reaches 190,000 and 270,000 Baht per QALY using
societal and government perspective respectively.
Discussion
The study provides the same results using the two differ-
ent viewpoints of the analysis; LC is a more expensive but
likely to provide a better quality of life than OC. At base-
case scenario the ratio of extra cost of LC to its extra utility
gained varies between 89,000 and 134,000 Baht per
QALY, depending on whether indirect costs are included.
To make the model as simple as possible and to focus only
on a comparison between the use of OC and LC, the
model has a limitation about retained CBD stones
between the two strategies. Retained CBD stones could
arise from a difference in the use of ERCP and IOC
between the two approaches. However, estimating the
sensitivity and specificity of IOC and ERCP is not straight-
forward since the two investigations and surgery are not
performed simultaneously, so it is possible that the stones
can migrate out of the CBD spontaneously in the interval
between investigation and surgery, or that additional
stones enter the CBD from the gallbladder. The review of
literature by Urbach et al[27] indicates that both IOC and
ERCP provided the same specificity in detecting CBD
stones but ERPC had superior sensitivity to IOC (95% vs
89%). In the other words, IOC would provide additional
5 false negative cases compared to ERCP. The literature
also reveals that not all retained stones would be a prob-
lem but only 15% of these would go on to cause clinical
problems[21]. Measuring QALYs for the retained CBD
stones is also problematic. We found no study assessing
utility of retained CBD stones.
The results of the economic evaluation for management
options for gallstone disease in Thailand are irrelevant to
comparable previous studies conducted in developed
countries of which Cook J et al[16] and Berggren et al[7]
found that LC was a cost saving strategy in comparison to
Cost-effectiveness acceptability curves using net benefit  approach Figure 2
Cost-effectiveness acceptability curves using net benefit 
approach.
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OC. The difference could be explained with two reasons.
Firstly, a higher wage rate for both health professionals
and patients in US and Australia caused a significant
higher hospital admission costs and opportunity cost of
taking sick-leave. Secondly, the indirect costs quantified
by the two studies are an overestimation, especially when
applied to the Thai context. Since, following guidance on
estimating 'friction costs' of lost work[28], the studies esti-
mated the costs by multiplying average employment costs
with proportion of population in the work force, but our
study found that only 50% and 53% of patients undergo-
ing open and laparoscopic cholecystectomy were active
workforce members. However, it may be important to add
a comment that this approach does not value the time of
people not in paid work, even though many are produc-
tive members of society, e.g. self employed farmers, or
unpaid house works.
Similar to the previous study[9], an operation cost con-
tributed to 75% of total hospital costs for LC compared to
20% for OC. More than two third (70%) of operation cost
was from operative instruments, although the sample
hospital was quite efficient in using these instruments
since, where possible, reusable instruments were intro-
duced. Thus, we believe there is a little room to make the
operation cost smaller.
To allow for the extra quality of life gained from LC, how-
ever, additional funding would be required. The judge-
ment about whether to advocate LC over OC in such
situations would depend on what benefit could be
obtained from the use of these extra resources elsewhere.
However, a broad comparison across health care interven-
tions is unlikely due to the fact that it would have had an
enormous work of analysis of possible treatments.
Another approach is setting a ceiling value for health ben-
efit that society is willing to pay. The committee for devel-
opment of Millennium Development Goals recommends
the use of three times of Gross Domestic Product (GDP)
per capital as a threshold for the consideration in develop-
ing countries. This application would presently lead to a
ceiling value in Thailand of 270,000 Baht. In this case, LC
is a cost-effective intervention. If extra funds could not be
obtained for the health system directly, resources would
have been obtained from elsewhere e.g. a co-payment sys-
tem.
Furthermore, economic evaluations are commonly criti-
cised by decision makers for ignoring budget impacts,
about which decision makers desperately concerned. Pay-
ers can get into financial difficulty if they adopt too many
cost-effectiveness interventions[29] and affordability,
which depends on the overall volume of patients, is there-
fore a prime concern. We projected the financial implica-
tion if pro LC policy is adopted in Thailand (table 4).
Assuming that 80% of patients who need cholecystectomy
eligible for LC, the government would require 96 million
Baht for supporting pro LC policy. At the same time,
households could save 40 million Baht from indirect
medical care cost resulted in the net of 56 million Baht
required by society as a whole.
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